Logo Image
|Articles|April 1, 2022

Skippy Recalls Some of its Creamy Peanut Butter

The Food and Drug Administration (FDA) said the company is concerned about a limited number of jars that may contain a small fragment of stainless steel from a piece of manufacturing equipment.


Earlier this week, Skippy Foods announced a recall of 9353 cases, or 161,692 total pounds, of a limited number of code dates of Skippy Reduced Fat Creamy Peanut Butter Spread, Skippy Reduced Fat Chunky Peanut Butter Spread and Skippy Creamy Peanut Butter Blended With Plant Protein due to the possibility that a limited number of jars may contain a small fragment of stainless steel from a piece of manufacturing equipment.

According to the company, the voluntary recall was done out of caution and with an emphasis on the quality of its products.

Listed below are the specific product lines and recalled code dates:


The company noted no other products are included in the recall, and for people who did purchase the recalled peanut butter, they can return it to their place of purchase for an exchange or call Skippy Foods Consumer Engagement at 1-866-475-4779 or visit the website for instructions and information.


This recall is being conducted with the knowledge of the FDA.

Related to this article

View more
How The Food Safety Surveillance Infrastructure Works in the US
How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Read more
NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.
Read more